3D細胞培養市場：製品、用途、エンドユーザー別-2025～2030年の世界予測

3D細胞培養市場の2023年の市場規模は19億米ドルで、2024年には20億4,000万米ドルに達すると予測され、CAGR 7.63％で成長し、2030年には31億9,000万米ドルに達すると予測されています。

生体細胞を生体内の環境に近い形で培養する革新的な技術は、生物医療研究の進展に不可欠です。その必要性は、従来の2次元培養と比較して、創薬、がん研究、組織工学において、より正確な予測データを提供する能力によって裏付けられています。3D細胞培養の開発は、医薬品開発、遺伝子研究、再生医療、個別化治療など多岐にわたります。最終用途セグメントは、バイオテクノロジー、学術機関、病院、診断ラボなどです。慢性疾患の増加と細胞培養技術の進歩が市場成長を促進する主要要因です。さらに、腫瘍環境を研究するための腫瘍学研究における3D培養の採用が増加していることも、大きな成長機会をもたらしています。市場の最新の可能性としては、臓器オンチップモデルやマイクロ流体技術の開発があり、動物実験に代わるより信頼性が高く倫理的な代替手段を提供することで、創薬や検査に革命をもたらすことができます。しかし、高コスト、技術の複雑さ、標準化されたプロトコルの欠如といった制約が、市場成長の大きな障壁となっています。さらに、複雑なデータを解釈するためには専門的な人材が必要であることも課題として残っています。技術革新の最良のセグメントとしては、無骨格システムの探求や、データ分析と予測モデリングを強化するための人工知能の統合が挙げられます。骨格用の新規生体材料やイメージング技術の強化に関する調査は、市場をさらに拡大させる可能性があります。投資家や企業は、最先端のイノベーションのために学術機関との戦略的パートナーシップに注力し、コストを下げるために拡大性のある技術に投資すべきです。全体として、3D細胞培養市場は急速な進化と競合市場競争によるイノベーションを特徴としており、新たな動向を活用し成長を促進するためには、企業の敏捷性と先見的な戦略が必要となります。複雑な状況を乗り切り、包括的なソリューションを提供できる企業は、拡大する市場機会を活用するのに有利な立場にあると考えられます。

市場力学：急速に進化する3D細胞培養市場の主要市場洞察を公開

3D細胞培養市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の再生医療重視の高まり
  • 薬剤耐性と薬剤リポジショニングに対する3D細胞培養の採用
  • 細胞ベースの研究開発活動と投資の増加
• 市場抑制要因
  • 3D細胞培養開発に必要な高コストと複雑なインフラ
• 市場機会
  • 精密医療をサポートする3D細胞培養技術の進歩
  • 臓器オンチップモデルに対する認識と採用の高まり
• 市場課題
  • 3D細胞培養の拡大性の制限と標準化の欠如

ポーターのファイブフォース：3D細胞培養市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、3D細胞培養市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：3D細胞培養市場における外部からの影響の把握

外部マクロ環境要因は、3D細胞培養市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：3D細胞培養市場における競合情勢の把握

3D細胞培養市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：3D細胞培養市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、3D細胞培養市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：3D細胞培養市場における成功への道筋を描く

3D細胞培養市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で再生医療への注目が高まる
    • 薬剤耐性と薬剤再配置のための3D細胞培養の採用
    • 細胞ベースの研究における研究開発活動と投資の増加
  • 抑制要因
    • 3D細胞培養開発にはコストが高く、インフラ要件が複雑
  • 機会
    • 精密医療を支える3D細胞培養技術の進歩
    • 臓器チップモデルに対する認識と採用の高まり
  • 課題
    • スケーラビリティが限られており、3D細胞培養が標準化されていない
• 市場セグメンテーション分析
  • 製品：質的利点と機能性により、スキャフォールドフリー3D細胞培養の採用が増加
  • 用途：薬剤の有効性を維持するための創薬における3D細胞培養の応用が増加
  • エンドユーザー：細胞挙動を理解するためのラボでの3D細胞培養技術の採用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 3D細胞培養市場：製品別

• イントロダクション
• 3Dバイオプリンティング
• 磁気浮上
• マイクロ流体ベースの3D細胞培養
• スキャフォールドベースの3D細胞培養
• スキャフォールドフリーの3D細胞培養

第7章 3D細胞培養市場：用途別

• イントロダクション
• がん
• 創薬
• 幹細胞研究
• 組織工学と再生医療
• 毒物学

第8章 3D細胞培養市場：エンドユーザー別

• イントロダクション
• 製薬・バイオテクノロジー企業
• ラボ・研究機関

第9章 南北アメリカの3D細胞培養市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の3D細胞培養市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの3D細胞培養市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • AmsbioがmCollaFibRを発表：3D細胞培養のイノベーション
  • Fujifilm、細胞培養能力強化のためノースカロライナ州で12億米ドルの拡大を発表
  • Molecular Devices、迅速で信頼性の高い創薬を実現する3D生物学イノベーションハブ、CellXpress.ai自動細胞培養システムを発表
  • InSpheroとAdvanced BioMatrixが販売契約を締結し、3D細胞培養の応用範囲をスキャフォールドベースのモデルに拡大
  • 3D BioFibRは、2つのCollaFibR組織工学製品の発売により、バイオプリンティングと3D細胞培養市場に参入
• 戦略分析と提言

企業一覧

• 3D BIoTek, LLC
• Altis Biosystems, Inc.
• Avantor, Inc.
• Becton, Dickinson and Company
• BellBrook Labs
• Cellink by Bico Group
• CN Bio Innovations Limited
• Copner BIoTech
• Corning Inc.
• Curesponse Ltd.
• Electrospinning Company Ltd.
• Emulate, Inc.
• Greiner Bio-One International GmbH
• Hamilton Company
• InSphero AG
• JSR Corporation
• Known Medicine
• Lonza Group AG
• MEGAROBO Technologies Co., Ltd.
• Merck KGaA
• MIMETAS
• Ovizio Imaging Systems SA/NV
• PELOBIOTECH GmbH
• Promega Corporation
• PromoCell GmbH
• Reprocell Inc.
• SARSTEDT AG & Co. KG
• Spiderwort Inc.
• Synthecon Inc.
• Tecan Trading AG
• Thermo Fisher Scientific, Inc.
• TissUse GmbH
• TreeFrog Therapeutics SAS

LIST OF FIGURES

• FIGURE 1. 3D CELL CULTURE MARKET RESEARCH PROCESS
• FIGURE 2. 3D CELL CULTURE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. 3D CELL CULTURE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. 3D CELL CULTURE MARKET DYNAMICS
• TABLE 7. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL 3D CELL CULTURE MARKET SIZE, BY 3D BIO PRINTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL 3D CELL CULTURE MARKET SIZE, BY MAGNETIC LEVITATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL 3D CELL CULTURE MARKET SIZE, BY MICROFLUIDICS-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-FREE 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL 3D CELL CULTURE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL 3D CELL CULTURE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL 3D CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL 3D CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL 3D CELL CULTURE MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL 3D CELL CULTURE MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. CANADA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. CANADA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. CHINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. CHINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. ITALY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. ITALY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. POLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. POLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. QATAR 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. QATAR 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

The 3D Cell Culture Market was valued at USD 1.90 billion in 2023, expected to reach USD 2.04 billion in 2024, and is projected to grow at a CAGR of 7.63%, to USD 3.19 billion by 2030.

3D cell culture, an innovative technique for growing biological cells in a way that closely mimics an in vivo environment, is critical for advancing biomedical research. Its necessity is underlined by its ability to provide more accurate predictive data in drug discovery, cancer research, and tissue engineering compared to traditional 2D cultures. Applications of 3D cell culture span pharmaceutical development, genetic studies, regenerative medicine, and personalized therapy. End-use sectors include biotechnology, academic institutions, hospitals, and diagnostic laboratories. The rise of chronic diseases and advancements in cell culture technology are key factors driving market growth. Additionally, the increasing adoption of 3D cultures in oncology research to study tumor environments offers substantial growth opportunities. The latest potential in the market includes developing organ-on-chip models and microfluidics tech that can revolutionize drug discovery and testing by providing more reliable and ethical alternatives to animal testing. However, limitations such as high costs, technical complexity, and lack of standardized protocols present significant barriers to market growth. Moreover, the requirement for specialized personnel to interpret complex data remains a challenge. Best areas of innovation include the exploration of scaffold-free systems and the integration of artificial intelligence to enhance data analysis and predictive modeling. Research into novel biomaterials for scaffolds and enhanced imaging techniques could further expand the market. Investors and companies should focus on strategic partnerships with academic institutions for cutting-edge innovation and invest in scalable technologies to lower costs. Overall, the 3D cell culture market is characterized by rapid evolution and competitive innovation, necessitating agility and forward-thinking strategies for businesses to leverage emerging trends and drive growth. Companies that can navigate the complexities and offer comprehensive solutions will be well-positioned to capitalize on the expanding market opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Cell Culture Market

The 3D Cell Culture Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing emphasis on regenerative medicine worldwide
  • Adoption of 3D cell culture for drug resistance and drug repositioning
  • Increasing R&D activities and investments in cell-based studies
• Market Restraints
  • High cost and complex infrastructure requirements for 3D cell culture development
• Market Opportunities
  • Advancements in 3D cell culture technologies to support precision medicine
  • Emerging awareness and adoption of organ-on-a-chip models
• Market Challenges
  • Limited scalability and lack of standardization of 3D cell culture

Porter's Five Forces: A Strategic Tool for Navigating the 3D Cell Culture Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Cell Culture Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Cell Culture Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Cell Culture Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Cell Culture Market

A detailed market share analysis in the 3D Cell Culture Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Cell Culture Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Cell Culture Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Cell Culture Market

A strategic analysis of the 3D Cell Culture Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Cell Culture Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek, LLC, Altis Biosystems, Inc., Avantor, Inc., Becton, Dickinson and Company, BellBrook Labs, Cellink by Bico Group, CN Bio Innovations Limited, Copner Biotech, Corning Inc., Curesponse Ltd., Electrospinning Company Ltd., Emulate, Inc., Greiner Bio-One International GmbH, Hamilton Company, InSphero AG, JSR Corporation, Known Medicine, Lonza Group AG, MEGAROBO Technologies Co., Ltd., Merck KGaA, MIMETAS, Ovizio Imaging Systems SA/NV, PELOBIOTECH GmbH, Promega Corporation, PromoCell GmbH, Reprocell Inc., SARSTEDT AG & Co. KG, Spiderwort Inc., Synthecon Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc., TissUse GmbH, and TreeFrog Therapeutics SAS.

Market Segmentation & Coverage

This research report categorizes the 3D Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across 3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture, Scaffold-based 3D Cell Culture, and Scaffold-free 3D Cell Culture.
• Based on Application, market is studied across Cancer, Drug Discovery, Stem Cell Research, Tissue Engineering & Regenerative Medicine, and Toxicology.
• Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing emphasis on regenerative medicine worldwide
    • 5.1.1.2. Adoption of 3D cell culture for drug resistance and drug repositioning
    • 5.1.1.3. Increasing R&D activities and investments in cell-based studies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and complex infrastructure requirements for 3D cell culture development
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in 3D cell culture technologies to support precision medicine
    • 5.1.3.2. Emerging awareness and adoption of organ-on-a-chip models
  • 5.1.4. Challenges
    • 5.1.4.1. Limited scalability and lack of standardization of 3D cell culture
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging adoption of scaffold-free 3D cell culture owing to their qualitative benefits and functionalities
  • 5.2.2. Application: Rising application of 3D cell cultures in drug discovery to maintain drug efficacy
  • 5.2.3. End-User: Adoption of 3D cell culture technology in research labs for understanding cell behavior
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. 3D Cell Culture Market, by Product

• 6.1. Introduction
• 6.2. 3D Bio Printing
• 6.3. Magnetic Levitation
• 6.4. Microfluidics-based 3D Cell Culture
• 6.5. Scaffold-based 3D Cell Culture
• 6.6. Scaffold-free 3D Cell Culture

7. 3D Cell Culture Market, by Application

• 7.1. Introduction
• 7.2. Cancer
• 7.3. Drug Discovery
• 7.4. Stem Cell Research
• 7.5. Tissue Engineering & Regenerative Medicine
• 7.6. Toxicology

8. 3D Cell Culture Market, by End-User

• 8.1. Introduction
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Research Laboratories & Institutes

9. Americas 3D Cell Culture Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific 3D Cell Culture Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa 3D Cell Culture Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Amsbio Introduces mCollaFibR: Innovations in 3D Cell Culture
  • 12.3.2. Fujifilm Announces USD 1.2 Billion Expansion in North Carolina for Enhanced Cell Culture Capacities
  • 12.3.3. Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
  • 12.3.4. InSphero and Advanced BioMatrix Signed a Distribution Agreement to Expand the Application Range in 3D Cell Culture Into Scaffold-Based Models
  • 12.3.5. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3D Biotek, LLC
• 2. Altis Biosystems, Inc.
• 3. Avantor, Inc.
• 4. Becton, Dickinson and Company
• 5. BellBrook Labs
• 6. Cellink by Bico Group
• 7. CN Bio Innovations Limited
• 8. Copner Biotech
• 9. Corning Inc.
• 10. Curesponse Ltd.
• 11. Electrospinning Company Ltd.
• 12. Emulate, Inc.
• 13. Greiner Bio-One International GmbH
• 14. Hamilton Company
• 15. InSphero AG
• 16. JSR Corporation
• 17. Known Medicine
• 18. Lonza Group AG
• 19. MEGAROBO Technologies Co., Ltd.
• 20. Merck KGaA
• 21. MIMETAS
• 22. Ovizio Imaging Systems SA/NV
• 23. PELOBIOTECH GmbH
• 24. Promega Corporation
• 25. PromoCell GmbH
• 26. Reprocell Inc.
• 27. SARSTEDT AG & Co. KG
• 28. Spiderwort Inc.
• 29. Synthecon Inc.
• 30. Tecan Trading AG
• 31. Thermo Fisher Scientific, Inc.
• 32. TissUse GmbH
• 33. TreeFrog Therapeutics SAS